Aclaris therapeutics to participate in the virtual svb securities global biopharma conference

Wayne, pa., feb. 09, 2023 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the aclaris management team will participate in a fireside chat during the virtual svb securities global biopharma conference on tuesday, february 14, 2023 at 9:20 am et.
ACRS Ratings Summary
ACRS Quant Ranking